A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Investors in Pfizer Inc. (NYSE:PFE) need to pay close attention to the stock based on moves in the options market lately. That... One stock that might be an intriguing choice for investors right ...

VBI Vaccines (NASDAQ:VBIV) Inc. VBIV announced an update on the progress of its two vaccine candidates for COVID-19. The first ...

Relay Therapeutics, Inc.’s RLAY share price has dipped by 6.00%, which has investors questioning if this is right time to buy.